Search company, investor...
The Edelman Financial Group company logo

The Edelman Financial Group

edelmanfinancial.com

Stage

Acquired

Investors Count

3

Deal Terms

1

Portfolio Exits

2

Investments

7

Funding, Valuation & Revenue

3 Fundings

The Edelman Financial Group's latest funding round was a Merger for on July 23, 2018.

The Edelman Financial Group's valuation in September 2012 was $258M.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

7/23/2018

Merger

$XXM

0

FY undefined

1

10/13/2015

Acq - Fin - II

$XXM

0

FY undefined

10

9/14/2012

Acq - Fin

$258M

0

FY undefined

0

Date

7/23/2018

10/13/2015

9/14/2012

Round

Merger

Acq - Fin - II

Acq - Fin

Amount

Investors

Valuation

$XXM

$XXM

$258M

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

Sources

1

10

0

You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo
CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

The Edelman Financial Group Deal Terms

1 Deal Term

The Edelman Financial Group's deal structure is available for 1 funding round, including their Acq - Fin from September 14, 2012.

Round

Acq - Fin

Funding Date

$XXM

Pre-Money Valuation

Post-Money Valuation

$XXM

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$XXM

Board Voting

$XXM

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Acq - Fin

$XXM

$XXM

$XXM

$XXM

The Edelman Financial Group Investors

3 Investors

The Edelman Financial Group has 3 investors. Edelman Financial Engines invested in The Edelman Financial Group's Merger funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

7/23/2018

7/23/2018

1
Merger

Asset/Investment Management

California

00/00/0000

00/00/0000

Hellman & Friedman

Subscribe to see more

Private Equity

California

00/00/0000

00/00/0000

Lee Equity Partners

Subscribe to see more

Private Equity

New York

First funding

7/23/2018

00/00/0000

00/00/0000

Last Funding

7/23/2018

00/00/0000

00/00/0000

Investor

Hellman & Friedman

Lee Equity Partners

Rounds

1
Merger

Subscribe to see more

Subscribe to see more

Board Seats

Type

Asset/Investment Management

Private Equity

Private Equity

Location

California

California

New York

The Edelman Financial Group Investments

7 Investments

The Edelman Financial Group has made 7 investments. Their latest investment was in Direvo Biotech as part of their Series B on November 26, 2002.

CBI Logo

The Edelman Financial Group Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

11/26/2002

Series B

Direvo Biotech

$10.51M

Yes

Danisco Venture, Mulligan BioCapital, TVM Capital Life Science, Undisclosed Angel Investors, and Undisclosed Investors

1

5/29/2002

Seed

Subscribe to see more

$XXM

Subscribe to see more

10

3/14/1997

Growth Equity - II

Subscribe to see more

$XXM

Subscribe to see more

10

8/9/1996

Growth Equity

Subscribe to see more

$XXM

Subscribe to see more

10

4/1/1991

Series C

Subscribe to see more

$XXM

Subscribe to see more

10

Date

11/26/2002

5/29/2002

3/14/1997

8/9/1996

4/1/1991

Round

Series B

Seed

Growth Equity - II

Growth Equity

Series C

Company

Direvo Biotech

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$10.51M

$XXM

$XXM

$XXM

$XXM

New?

Yes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Danisco Venture, Mulligan BioCapital, TVM Capital Life Science, Undisclosed Angel Investors, and Undisclosed Investors

Sources

1

10

10

10

10

The Edelman Financial Group Portfolio Exits

2 Portfolio Exits

The Edelman Financial Group has 2 portfolio exits. Their latest portfolio exit was Direvo Biotech on September 16, 2008.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

9/16/2008

Acquired

$XXM

3/14/1997

Reverse Merger

Subscribe to see more

$XXM

Subscribe to see more

0

Date

9/16/2008

3/14/1997

Exit

Acquired

Reverse Merger

Companies

Subscribe to see more

Valuation

$XXM

$XXM

Acquirer

Subscribe to see more

Sources

0

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.